EMEA-000876-PIP06-15

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Eculizumab

Decision numberP/0201/2016
PIP numberEMEA-000876-PIP06-15
Pharmaceutical form(s)Concentrate for solution for infusion
Condition(s)/indication(s)

Prevention of graft rejection following solid organ transplantation

Route(s) of administrationIntravenous use
PIP applicant

Alexion Europe SAS
France
Tel. +33 147100606
Fax +33 147100611
E-mail: pip.enquiries@alxn.com
 

Decision typeP: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision